ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 221 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q1 2022. The put-call ratio across all filers is 1.42 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,097,303 | -18.2% | 201,340 | +0.8% | 0.03% | -33.3% |
| Q2 2023 | $1,340,926 | -15.0% | 199,840 | +11.9% | 0.04% | -12.5% |
| Q1 2023 | $1,576,914 | -99.8% | 178,586 | +24.5% | 0.05% | +152.6% |
| Q3 2022 | $1,022,000,000 | -40.8% | 143,490 | -32.8% | 0.02% | -24.0% |
| Q2 2022 | $1,727,000,000 | – | 213,490 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TIGER MANAGEMENT L.L.C. | 1,115,411 | $37,913,000 | 7.02% |
| Eagle Health Investments LP | 441,466 | $15,005,000 | 4.76% |
| Rappaport Reiches Capital Management, LLC | 133,330 | $4,531,887 | 4.48% |
| Matrix Capital Management Company, LP | 11,572,590 | $393,352,000 | 4.48% |
| VIKING GLOBAL INVESTORS LP | 29,993,708 | $1,019,486,000 | 2.80% |
| Aristotle Atlantic Partners, LLC | 727,334 | $24,722,000 | 1.64% |
| DDD Partners, LLC | 316,927 | $10,772,000 | 1.61% |
| Hedeker Wealth, LLC | 117,500 | $3,993,000 | 1.23% |
| Casdin Capital, LLC | 1,440,000 | $48,946,000 | 1.22% |
| BERYLSON CAPITAL PARTNERS, LLC | 61,000 | $2,073,000 | 0.96% |